Group Medical Visits for Patients With Dyslipidemia

NCT07543718 | Recruiting

• 1 other identifier: CIHR550827
• Study Type: interventional
• Target: 288
• Locations: 1 country
• Sites: 1

Brief Summary

Physicians' interventions to promote the improvement of lifestyle habits have been shown to be effective. However, such interventions remain underutilized due to barriers such as lack of time, confidence, and compensation. Group medical visits (GMVs) can help overcome several of these barriers and effectively improve clinical indicators as well as patients' quality of life. GMVs could also reduce pressure on the healthcare system by improving access to primary care through a more efficient use of resources. The literature suggests that GMVs can be effective in improving access to care and reducing disease complications for patients with several conditions and risk factors, but they have not been assessed specifically among patients with dyslipidemia, which is at the origin of most cases of cardiovascular diseases. In this context, GMVs will be implemented among 144 patients with dyslipidemia. The objective for this project is to evaluate implementation of GMVs. The implementation evaluation will follow the RE-AIM framework. These steps will position the research team to develop more complex and large-scale studies in lifestyle medicine. In the meantime, the project will contribute to improve access to primary care for the prevention of cardiovascular diseases.

Conditions

Dyslipidemias

Outcome Measures

Primary Outcomes (1)

• Lipid profile

  Low-Density Lipoprotein; High-Density Lipoprotein; Total cholesterol; Triglycerides

  12 months

Secondary Outcomes (12)

• Recruitment proportion

  12 months

• Representativeness of eligible patients

  12 months

• Attitudes of health professionals towards GMVs

  12 months

• Frequency of access to healthcare

  12 months

• Patients' self-efficacy

  12 months

Study Arms (2)

Intervention group

EXPERIMENTAL

The intervention consists of regular care supplemented by a series of group medical visits (GMVs). Each series of GMVs will last 9-12 months and will include eight sessions of 90-120 minutes covering topics related to lifestyle medicine within the context of dyslipidemia management. These sessions will be offered to groups of 8 to 12 patients and delivered by a mix of family physicians, dietitians, kinesiologists, and psychologists, all trained to deliver GMVs. Each session will begin with a revision of the goals established in the previous session, followed by a didactic component including demonstrations, questioning, and experiential activities. Emphasis will be placed on health self management and on developing realistic, specific, and observable personal goals. The sessions will include opportunities for social interaction among participants and will offer opportunities for brief one on one consultations patients and health professionals if needed.

Behavioral: Group medical visits

Usual care group

NO INTERVENTION

Participants in the usual-care group will have access to their regular follow-up with their primary care providers. They will also have the option to take part in the GMVs after the project's final evaluation period.

Interventions

Group medical visits BEHAVIORAL

Group medical visits are designed to improve knowledge of participants and promote self-management.

Intervention group

Eligibility Criteria

• Age: 40 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of dyslipidemia according to the guidelines of the Canadian Cardiovascular Society, i.e., at a minimum: an intermediate cardiovascular risk according to the Framingham Risk Score (10-19.9%) WITH LDL-C ≥ 3.5 mmol/L or non-HDL-C ≥ 4.2 mmol/L or ApoB ≥ 1.05 g/L

You may not qualify if:

• Patients unable to participate in GMV sessions or to provide informed consent
• Patients with a mental health condition likely to limit their ability to benefit from GMV sessions and discussions (Examples: severe dementia or an acute psychiatric decompensation occurring within the past six months)
• A diagnosis of terminal illness or a life expectancy of less than 12 months

Sponsors & Collaborators

• Université de Sherbrooke: lead

Study Sites (1)

Unité de médecine familiale du Grand-Moncton

Dieppe, New Brunswick, E1A1G6, Canada

RECRUITING

MeSH Terms

Conditions

Dyslipidemias

Condition Hierarchy (Ancestors)

Lipid Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases

Central Study Contacts

Mathieu Belanger, PhD

CONTACT

5068632221; mathieu.f.belanger@usherbrooke.ca

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 27, 2026
• First Posted: April 22, 2026
• Study Start: April 1, 2026
• Primary Completion (Estimated): January 1, 2030
• Study Completion (Estimated): December 1, 2030
• Last Updated: April 22, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, CSR
• Time Frame: within 12 months after publication of the main results.

Locations

CA (1)